Global Virtual Clinical Trials Market Forecast 2035:
According to the report, the global virtual clinical trials market is likely to grow from USD 6.6 Billion in 2025 to USD 11.7 Billion in 2035 at a highest CAGR of 5.9% during the time period. The virtual clinical trials market is expanding rapidly because of the increased use of decentralized and hybrid trial methods, more patient-focused research being conducted, and the need for quicker, less expensive delivery of drugs. Sponsors of the research are using increasingly more digital platforms to conduct patient visits remotely; collect electronic patient-reported outcome (ePRO) data; and manage the clinical trial data as it is being collected.
This helps improve the efficiency of the trial and improve the accuracy of the data being collected while helping to ensure that the trial adheres to the regulations governing it. Additionally, the pharmaceutical and biotechnology industries are utilizing virtual trial technology to enhance patient recruitment, patient monitoring, and patient retention. The integration of artificial intelligence (AI) with other technologies like wearable tech and cloud-based analytics allows for real-time insights regarding patient behavior and predicting future patient behavior.
Lastly, mobile health applications used by patients allow for remote participation in a clinical trial, electronic consent and continuous patient monitoring, which creates new opportunities for all parties involved in the clinical trial, such as sponsors and patients.
Key Driver, Restraint, and Growth Opportunity Shaping the Global Virtual Clinical Trials Market
The global virtual clinical trials market experiences growth because researchers now use digital trial platforms to conduct patient-centric studies which help them recruit participants and handle electronic consent and track treatment results through remote methods. Sponsors use these platforms to enhance patient engagement and operational efficiency while collecting data because more patients prefer to take part in research from their homes. Notably, Science 37 expanded its virtual trial capabilities in 2023 to support remote oncology trials which operated throughout the United States.
The challenge involves maintaining accurate data while following compliance requirements because organizations need to unify various data sources which include wearable devices and electronic health records and patient-reported outcomes. The process becomes more challenging because organizations need to validate their data while trying to connect different systems which increases their operational expenses during their multiple site studies that involve various populations.
Moreover, the current industry standards for remote monitoring tools have not solved the main issue which prevents organizations from using wearable data in their centralized systems because they need to address three major problems which include standardization issues and privacy breaches and interoperability gaps. The increased need for manual validation procedures has resulted from multiple regulatory agencies which require compliance before organizations can use their wearable data.
Virtual clinical trials show strong potential to advance rare disease research because decentralized models enable patients from remote and underserved areas to participate without travel, which results in better trial population accessibility and diversity.
Notably, the 2025 IQVIA Holdings Inc. award recognized the company as a worldwide leader in decentralized and virtual trial technologies because it operates more than 200 decentralized clinical studies which help sponsors develop remote and hybrid systems to improve patient monitoring and engagement throughout different therapeutic areas. Virtual research models have developed into essential tools for researchers who need to reach particularly rare and hard-to-access patient groups.
Expansion of Global Virtual Clinical Trials Market
Technological Innovation, Patient-Centric Models, and Regulatory Support Driving the Global Virtual Clinical Trials Market Expansion
- The virtual clinical trials market is expanding because three elements, which include technological innovation and patient‑centric models and regulatory support, are changing the design and execution of clinical research throughout different medical fields.
- The trial efficiency gains and operational cost reductions and data quality improvements result from rapid technological advancements, which include artificial intelligence-enabled patient recruitment combined with remote monitoring through wearable sensors and cloud-based clinical data platforms and sophisticated telehealth capabilities. The innovations enable sponsors to gather real-time patient data while they track protocol violations which speeds up study progress and decreases their need for study sites.
- IQVIA Holdings Inc. expanded its decentralized trial tools in 2024 by adding AI-based analytics and remote patient monitoring capabilities which support more flexible study designs. The increasing interest in patient-centric models has led to higher adoption rates of virtual and hybrid trials which provide greater ease of participation for study subjects.
- Digital consent (eConsent), electronic patient‑reported outcomes (ePRO), and mobile health applications are enabling patients to participate from their homes while these tools help solve problems related to recruitment and retention. Science 37 conducted fully remote oncology studies throughout multiple U.S. regions in 2023 to create a real-life example of virtual research that centers on patient needs.
- Regulatory agencies such as the U.S. Food and Drug Administration and European Medicines Agency have provided guidance that supports decentralized medical research by establishing compliance requirements and promoting secure digital data management which helps build industry trust. The combination of these factors leads to further market expansion.
Regional Analysis of Global Virtual Clinical Trials Market
- North America has the largest number of virtual clinical trials because of its well-established digital health infrastructure, presence of pharmaceutical and biotechnology companies and supportive government regulations. Further, high rates of chronic and complicated diseases requiring ongoing treatment, availability of telehealth networks and covered insurance benefits from Medicare and private plans facilitate extensive participation by patients remotely.
- Additionally, North America's position as the leading region for virtual clinical trials is further enhanced by significant investments in Artificial Intelligence-driven clinical trial platforms, cloud-based clinical data management systems and decentralized clinical trial solutions.
- Asia Pacific is the region expected to experience the strongest growth in virtual clinical trials due to increasing digitization of healthcare in this region, increased awareness of patient-centered research and the need to improve access to clinical trials in rural areas and underserved populations.
- Some of the factors leading to increased participation by patients are mobile healthcare applications that were used during COVID-19, affordable decentralized trial technology solutions, and government efforts, such as the National Digital Health Mission launched by the Government of India.
- The partnership between domestic start-ups with global clinical trial technology companies, as well as the continued expansion of telehealth in China, Japan and Southeast Asia, are expected to result in double-digit growth in the Asia Pacific, making it the fastest growing region in the global virtual clinical trials market.
Prominent players operating in global virtual clinical trials market include prominent companies such as Castor Research Inc., Clario (ERT Clinical), Clinical Ink, Inc., CRF Health, Inc., Curebase, Inc., Dassault Systèmes SE (Medidata Solutions), ICON plc, IQVIA Holdings Inc., Labcorp Holdings Inc., Lightship, Inc., Medable, Inc., ObvioHealth, Inc., Oracle Corporation, Parexel International Corporation, Science 37, Inc., Signant Health Holding Corp., Syneos Health, Inc., Thermo Fisher Scientific Inc. (PPD, Inc.), THREAD Research, Inc., Veeva Systems Inc., along with several other key players.
The global virtual clinical trials market has been segmented as follows:
Global Virtual Clinical Trials Market Analysis, by Trial Type
- Fully Decentralized Trials
- Hybrid Trials
- Site-Based Trials with Virtual Components
Global Virtual Clinical Trials Market Analysis, by Study Design
- Interventional Studies
- Observational Studies
- Expanded Access Studies
Global Virtual Clinical Trials Market Analysis, by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Global Virtual Clinical Trials Market Analysis, by Component
- Software Platforms
- Clinical Trial Management Systems (CTMS)
- Electronic Data Capture (EDC) Systems
- Electronic Clinical Outcome Assessment (eCOA) Platforms
- Electronic Patient-Reported Outcome (ePRO) Systems
- eConsent Platforms
- Telemedicine and Virtual Visit Platforms
- Remote Patient Monitoring (RPM) Software
- Patient Recruitment and Engagement Platforms
- Randomization and Trial Supply Management (RTSM) Systems
- Clinical Data Management Systems (CDMS)
- Digital Biomarker Analytics Platforms
- AI-Based Clinical Trial Analytics Platforms
- Data Integration and Interoperability Platforms
- Regulatory Compliance and Documentation Software
- Others
- Services
- Decentralized Clinical Trial (DCT) Design and Consulting
- Virtual Clinical Trial Implementation Services
- Patient Recruitment and Retention Services
- Remote Monitoring and Site Management Services
- Telehealth and Virtual Visit Support Services
- Home Healthcare and Mobile Nursing Services
- Data Management and Biostatistics Services
- Regulatory Affairs and Compliance Services
- Logistics and Drug Supply Management
- Technology Integration and Platform Support
- Training and Technical Support Services
- Others
- Hardware and Connected Devices
- Wearable Health Monitoring Devices
- Biosensors and Digital Biomarker Devices
- Smart Medical Devices (Connected Devices)
- Remote Diagnostic Devices
- Mobile Devices (Smartphones and Tablets)
- Patient Monitoring Equipment
- Home-Based Clinical Trial Kits
- Smart Medication Adherence Devices
- Telehealth Communication Devices
- Portable Diagnostic and Imaging Devices
- Others
Global Virtual Clinical Trials Market Analysis, by Technology
- Telemedicine Platforms
- Electronic Data Capture (EDC) Systems
- eConsent Platforms
- Mobile Health (mHealth) Applications
- Wearable Devices and Biosensors
- Remote Patient Monitoring Platforms
- Clinical Trial Management Systems (CTMS)
- eClinical Platforms
- Others
Global Virtual Clinical Trials Market Analysis, by Therapeutic Area
- Oncology
- Cardiovascular Diseases
- Central Nervous System (CNS) Disorders
- Infectious Diseases
- Metabolic and Endocrine Disorders
- Respiratory Diseases
- Immunology and Autoimmune Diseases
- Rare Diseases
- Others
Global Virtual Clinical Trials Market Analysis, by Patient Engagement Model
- Direct-to-Patient Trials
- Home Healthcare Supported Trials
- Hybrid Patient Engagement Models
Global Virtual Clinical Trials Market Analysis, by Data Collection Method
- Electronic Patient-Reported Outcomes (ePRO)
- Sensor and Wearable-Based Monitoring
- Mobile App-Based Data Collection
- Teleconsultation and Virtual Visits
- Others
Global Virtual Clinical Trials Market Analysis, by End User
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Medical Device Companies
- Academic and Research Institutes
- Others
Global Virtual Clinical Trials Market Analysis, by Region
- North America
- Europe
- Asia Pacific
- Middle East
- Africa
- South America
About Us
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
Contact Us
USA Address:
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
info@marketgenics.co
India Address:
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
sales@marketgenics.co